Literature DB >> 15797788

Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.

Paola Bertocchi1, Eleonora Antoniella, Luisa Valvo, Stefano Alimonti, Adriana Memoli.   

Abstract

The aim of this work was to compare the dissolution behaviour of six diclofenac sodium prolonged release tablets of different brands obtained from the national market. The formulations contain the same amount of drug substance but different types and/or amount of excipients. The influence of these differences in formulation on the release characteristics of the dosage forms was evaluated on the European Pharmacopoeia apparatus 2 (paddle) employing eight different dissolution media in the pH range 1.2-8. Friability and hardness were tested too according to the European Pharmacopoeia. Dissolution profiles obtained from the studied formulations showed that the release characteristics vary considerably among different manufacturers and that even identical formulations show rather dissimilar release profiles in all the studied media. Use of both SIF without pancreatin and SIF without pancreatin containing 1% (w/v) Tween 20 resulted in strong discrimination among products. A correlation between friability and hardness and in vitro dissolution was evidenced for two formulations having identical excipient composition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15797788     DOI: 10.1016/j.jpba.2004.11.041

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing.

Authors:  Mubarak Nasser Al Ameri; Nanda Nayuni; K G Anil Kumar; David Perrett; Arthur Tucker; Atholl Johnston
Journal:  Results Pharma Sci       Date:  2011-12-07

2.  Hepatotoxic mechanism of diclofenac sodium on broiler chicken revealed by iTRAQ-based proteomics analysis.

Authors:  Chuanxi Sun; Tianyi Zhu; Yuwei Zhu; Bing Li; Jiaming Zhang; Yixin Liu; Changning Juan; Shifa Yang; Zengcheng Zhao; Renzhong Wan; Shuqian Lin; Bin Yin
Journal:  J Vet Sci       Date:  2022-05-25       Impact factor: 1.603

3.  Tablet Formulation of 2-((3-(Chloromethyl)benzoyl)oxy)benzoic Acid by Linear and Quadratic Models.

Authors:  Wuryanto Hadinugroho; Kuncoro Foe; Yudy Tjahjono; Caroline Caroline; Senny Yesery Esar; Hendy Wijaya; Maria Annabella Jessica
Journal:  ACS Omega       Date:  2022-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.